Stockholm 01.11.2018. Hadean Ventures is pleased to announce the appointment of Roger Franklin PhD as Partner to be based in Hadean’s Stockholm office at the Karolinska Institute Science Park. Roger has over a decade of experience in the life science industry in various senior roles within the venture capital, investment banking and strategy consulting sectors. Prior to his business career, Roger specialised in oncology during his doctoral work at Cambridge’s Laboratory of Molecular Biology (LMB). He completed his academic training in biochemistry at Oxford University.
Roger will be based in Stockholm, Sweden, a location that is core to the company’s determined focus on regions of Europe with truly outstanding science and innovation yet which are relatively underserved by specialist venture finance. At the sector level, Roger will be particularly focused on therapeutics opportunities.
Commenting on his appointment, Roger said: “I am delighted to join Hadean at this very exciting time and look forward to working with the talented team as well as its strong group of investors. I strongly believe in the opportunity presented by combining the exceptional science generated in the region with specialist venture capital in this vibrant life-science ecosystem”.
Managing Partner, Ingrid Teigland Akay, commented: “We are pleased Roger is joining us to head up our office in Stockholm, which is key to our strategy in the Nordic region. We believe Roger will bring significant experience across venture and public market transactions as well as adding to our scientific, technical and operational expertise particularly in the area of therapeutics.”
Managing Partner, Walter Stockinger, said: “Having worked with Roger extensively in the past, we are convinced he will be a strong asset for our team and a great partner for our portfolio companies. Roger combines in-depth knowledge of the healthcare sector with a strong scientific and strategic background. Most importantly, Roger’s team-focused approach will help us achieving our objective of becoming a leading life-science fund manager in Europe”.
About Hadean Ventures:
Hadean Ventures is a European life science fund manager that invests in life science companies across Europe with a particular focus on the Nordic region. Hadean Ventures is managing funds backed by leading private and institutional investors including Saminvest and Argentum. Hadean Ventures has offices in Oslo and Stockholm and collaborates with world-class academic institutions and start-up hubs across the region.
Ingrid Teigland Akay, Hadean Ventures, Managing Partner
[email protected], +47 41140967